Pakistan to conduct phase-III clinical trial of Covid-19 vaccine

According to a statement from the national institute of health (NIH), it has obtained "formal approval" from the drug regulatory authority of Pakistan (DRAP) for phase-III Clinical Trial of Recombinant Novel Coronavirus Vaccine Adenovirus Type 5 vector (Ad5-nCoV) developed by CanSinoBio and Beijing Institute of Biotechnology China (BIB)".

from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/32h8rgL

About swapanpk